CAI vs CLDX Stock Comparison
CAI currently leads CLDX in this stock comparison, with AIQ scores of 70 vs 43. The clearest difference is quality, while CLDX has the stronger risk resilience profile.
What is the main difference between CAI and CLDX?
CAI leads the current stock comparison as Caris Life Sciences, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Caris Life Sciences, Inc. vs Celldex Therapeutics, Inc.
CAI leads
CAI leads by 27 AIQ points, primarily on Quality and Momentum. Wall Street currently favors CLDX on target upside.
Competitive: 3 of 5 evidence groups support CAI, and its current signal state is conflicted.
Caris Life Sciences, Inc.
Celldex Therapeutics, Inc.
The Algovestiq AIQ Score currently favors CAI over CLDX, 70 versus 43 as of Nov 15, 2026. CAI's advantage is driven primarily by stronger quality and momentum, while CLDX holds the stronger risk resilience profile. CAI also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors CLDX. 3 of 5 covered evidence groups favor CAI today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. CAI lead: Stable — the AIQ differential has held near 27 points over 30 sessions.
Compare Caris Life Sciences, Inc. and Celldex Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare CAI and CLDX against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality71 vs 30CAI +41
- Momentum85 vs 48CAI +37
- Risk Resilience36 vs 55CLDX +19
3 of 5 evidence groups favor CAI. CAI’s edge is concentrated in quality and momentum; CLDX keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum -1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 5 active signals are unchanged.
Largest factor move: Momentum +2
New signals
- Low Volume Rally Warning — bearish, volume, short horizon (0.57x)
CAI's lead narrowed by 2 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — CAI and CLDX both carry a full feed there.
The central trade-off
CAI (Caris Life Sciences, Inc.): the stronger current systematic profile, led by quality and momentum.
CLDX (Celldex Therapeutics, Inc.): the counter-case, on risk resilience, analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
CAICAI on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
CAICAI on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
CAICAI on the Momentum factor, by 37 points.
Lower downside
CLDXCLDX on Risk Resilience, by 19 points.
Analyst upside
CLDXCLDX on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors CAI, analyst targets favor CLDX. That disagreement is the most useful thing on this page.
| Measure | CAI | CLDX | Note |
|---|---|---|---|
| Implied upside to target | +64.9% | +140.2% | CLDX has more room |
| Target dispersion | 0% | +44.8% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 14 | 15 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 5 covered evidence groups favor CAI. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | CAI | 70 vs 43 |
| Fundamentals | CAI | revenue growth 4.4% vs -100%; EPS growth 22.7% vs -2.1%; TTM ROE 2.4% vs -11.6%; gross margin 69.1% vs -6.6%; operating margin 13.4% vs -2986.6% |
| Valuation | Not covered | Not covered |
| Technicals | CAI | Price vs 50-day -21.6% vs -9.8%; vs 200-day 6.5% vs -12.2% |
| Risk Resilience | CLDX | Risk Resilience 36 vs 55 |
| Analyst expectations | CLDX | Target upside 64.9% vs 140.2% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CAI and CLDX and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 27 points. (supports the conclusion holding)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CAI.
How the comparison changed
120 daily snapshots · May 27 – Nov 13CAI lead: Stable — the AIQ differential has held near 27 points over 30 sessions.
- Today
- CAI +27
- 70 vs 43
- 7 sessions ago
- CAI +31
- 72 vs 41
- 30 sessions ago
- CAI +29
- 71 vs 42
- 90 sessions ago
- CAI +2
- 64 vs 62
The lead changed hands 2 times in this window, most recently on Aug 14 when CAI moved ahead of CLDX.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 2 bearish / 2 neutral, conflicted
Only CAI
- Golden Cross Active — bullish, trend, long horizon (35.85%)
- ADX Trend Strengthening — neutral, trend, medium horizon
- Beta Spike Warning — bearish, risk_regime, long horizon
- Keltner Channel Breakdown — bearish, volatility, short horizon
0 bullish / 3 bearish / 1 neutral
Only CLDX
- Death Cross Active — bearish, trend, long horizon (2.70%)
- Downtrend Structure Active — bearish, trend, long horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.57x)
Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.
CAI leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -3.84%, AIQ 0 points).
Price and the AIQ Score both moved up over the latest session (price +1.05%, AIQ +2 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1CLDX closes the Quality gap — currently 41 points behind, the largest single contributor to CAI's edge.
- 2CLDX's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3CAI's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
CAI leads on balance| Metric | CAI | CLDX |
|---|---|---|
| Revenue growth (YoY) | 4.4% | -100% |
| EPS growth (YoY) | 22.7% | -2.1% |
| Gross margin | 69.1% | -6.6% |
| Operating margin | 13.4% | -2986.6% |
| Return on equity (TTM) | 2.4% | -11.6% |
| Debt to equity | 0.72 | 0.02 |
Performance
CLDX leads 4 of 6 windows| Metric | CAI | CLDX |
|---|---|---|
| 1 week (5 sessions) | -8.7% | -3.5% |
| 1 month (20 sessions) | -24.6% | 4.7% |
| 3 months (63 sessions) | 6.5% | -31.2% |
| 6 months (126 sessions) | 58.4% | -8% |
| Year to date | -14.6% | 6.1% |
| 1 year (252 sessions) | -7% | 18.9% |
Technicals
CAI has the stronger structure| Metric | CAI | CLDX |
|---|---|---|
| RSI (14) | 30.9 | 43.5 |
| ADX (14) | 37.3 | 17.1 |
| Price vs 50-day | -21.6% | -9.8% |
| Price vs 200-day | 6.5% | -12.2% |
| Volatility (1M, annualized) | 91.7% | 54.4% |
Risk
CLDX is the more resilient| Metric | CAI | CLDX |
|---|---|---|
| Beta | 1.85 | 1.22 |
| Sharpe ratio | 0.22 | 0.55 |
| Sortino ratio | 0.31 | 0.88 |
| Max drawdown | -49.6% | -38.6% |
| Current drawdown | -36.2% | -35.7% |
| Annualized volatility | 69.8% | 52.4% |
| Value at risk (95%) | -6.3% | -4.9% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, CAI or CLDX?
On the Algovestiq AIQ Score, CAI is the stronger of the two as of Nov 15, 2026, scoring 70 against CLDX's 43. The edge comes from quality and momentum. CLDX is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is CAI or CLDX the better buy right now?
CAI carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor CAI over CLDX?
The composite weights Quality, Value, Momentum and Risk Resilience. CAI leads Quality by 41 points; CAI leads Momentum by 37 points; CLDX leads Risk Resilience by 19 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, CAI or CLDX?
Analyst price targets imply +64.9% upside for CAI and +140.2% for CLDX, so the Street currently favors CLDX. That points the opposite way to the AIQ Score, which favors CAI. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, CAI or CLDX?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, CAI or CLDX?
CAI on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, CAI or CLDX?
CAI on the Momentum factor, by 37 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, CAI or CLDX?
CLDX is the more resilient of the two, so the other name carries the higher downside risk. CLDX on Risk Resilience, by 19 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is CAI more profitable than CLDX?
CAI leads on the comparable margin measures — gross margin 69.1% vs -6.6%; operating margin 13.4% vs -2986.6%; ttm roe 2.4% vs -11.6%.
Is CAI's lead over CLDX getting stronger or weaker?
CAI lead: Stable — the AIQ differential has held near 27 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 2 times in that window, most recently on 2026-08-14, when CAI moved ahead of CLDX.
What would change the CAI vs CLDX verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CLDX closes the Quality gap — currently 41 points behind, the largest single contributor to CAI's edge; CLDX's Death Cross Active resolves — a bearish trend rule currently active against it; CAI's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about CAI and CLDX?
CAI: 1 bullish / 2 bearish / 2 neutral, conflicted. CLDX: 0 bullish / 3 bearish / 1 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CAI is Golden Cross Active (bullish, long horizon). On CLDX it is Death Cross Active (bearish, long horizon).
Compare CAI and CLDX with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.